Patent Portfolios and Competition Law: Some Reflections After the Recent RPSA Cases
In the pharmaceutical sector, firms often build patent portfolios in order to better protect their innovations, but also to strategically exploit the cluster to prevent entry by generic competition. In fact, once patent protection on the main invention expires, originator firms adopt a two-tiered s...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade Católica Editora
2023-06-01
|
| Series: | Market and Competition Law Review |
| Subjects: | |
| Online Access: | https://revistas.ucp.pt/index.php/mclawreview/article/view/12677 |